SEARCH

SEARCH BY CITATION

FilenameFormatSizeDescription
ijs12158-sup-0001-si.doc85K

Table S1. Pharmacological properties of dabigatran, apixaban and rivaroxaban.

Table S2. Results of phase III trials of novel anticoagulants in atrial fibrillation.

Table S3. CHADS2 scores of patients included in RE-LY, ROCKET-AF, ARISTOTLE and AVERROES.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.